Scarica l'app Stockscreener
2.93
0.68%
-0.02
Dopo l'orario di chiusura:
2.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.95
Aprire:
$3.15
Volume 24 ore:
16,897
Relative Volume:
0.83
Capitalizzazione di mercato:
$6.54M
Reddito:
$5,000
Utile/perdita netta:
$-4.18M
Rapporto P/E:
-1.3045
EPS:
-2.2461
Flusso di cassa netto:
$-2.97M
1 W Prestazione:
-2.66%
1M Prestazione:
-11.75%
6M Prestazione:
+11.41%
1 anno Prestazione:
+4.64%
Intervallo 1D:
$2.90
$3.15
Intervallo di 1 settimana:
$2.67
$3.15
Portata 52W:
$1.67
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Nome
Alaunos Therapeutics Inc
Settore
Industria
Telefono
(346) 355-4099
Indirizzo
501 E LAS OLAS BLVD, FORT LAUDERDALE
Compare TCRT vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
2.93 | 6.54M | 5,000 | -4.18M | -2.97M | -2.2461 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-04 | Ripresa | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Borsa (TCRT) Ultime notizie
TCRT PE Ratio & Valuation, Is TCRT Overvalued - Intellectia AI
TCRT Technical Analysis & Stock Price Forecast - Intellectia AI
Ziopharm: Q4 Earnings Snapshot - kare11.com
Alaunos Therapeutics 10-K: Revenue $0.005M, Net loss $4.176M - TradingView
Cash runway, Nasdaq risks and obesity focus at Alaunos (TCRT) - Stock Titan
Inflation Data: Should value investors consider Alaunos Therapeutics IncQuarterly Investment Review & Community Consensus Trade Signals - baoquankhu1.vn
Weight loss data from obese mice looks promising for Alaunos Therapeutics, but shares drop - MSN
Aug Update: Is Alaunos Therapeutics Inc a cyclical or defensive stockTrend Reversal & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Contrasting Xeris Biopharma (NASDAQ:XERS) and Alaunos Therapeutics (NASDAQ:TCRT) - Defense World
TCRT,MLAC Revenue Breakdown - Finviz
Decliners Report: Can Alaunos Therapeutics Inc stock double in the next year2026 Trading Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
Aug Patterns: Is Alaunos Therapeutics Inc forming a bullish divergence2026 Dividend Review & Weekly Setup with High ROI Potential - baoquankhu1.vn
Short Interest in Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Decreases By 14.3% - Defense World
Shareholder group in Alaunos Therapeutics (TCRT) proposes $7M control-shifting investment - Stock Titan
Will Alaunos Therapeutics Inc benefit from rate cutsJuly 2025 Macro Moves & Safe Capital Growth Plans - baoquankhu1.vn
Alaunos reports early obesity drug data from mouse studies - Investing.com South Africa
TCRT SEC FilingsAlaunos Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Weight Loss Data From Obese Mice Looks Promising For Alaunos Therapeutics, But Shares Drop - Benzinga
Alaunos reports findings with ALN-1003 in DIO mouse model - bioworld.com
Alaunos Reports Positive Preclinical Data for Obesity Candidate - TipRanks
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders - The Manila Times
Alaunos Therapeutics reports positive preclinical ALN1003 data showing dose-dependent weight loss, liver improvements - TradingView
Non-hormonal obesity pill helps mice lose weight, improve liver health - Stock Titan
TCRT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Investors seek $7M Alaunos (TCRT) private placement and board seat - Stock Titan
MSN Money - MSN
Short Interest in Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Drops By 14.6% - Defense World
Chart Watch: Can Alaunos Therapeutics Inc stock double in the next yearJuly 2025 Price Swings & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Will Alaunos Therapeutics Inc. face regulatory challengesMarket Volume Summary & Fast Moving Stock Trade Plans - mfd.ru
How does Alaunos Therapeutics Inc. correlate with NasdaqJuly 2025 Reactions & Precise Buy Zone Tips - mfd.ru
Will Alaunos Therapeutics Inc. stock see PE expansion2025 Market WrapUp & Real-Time Buy Signal Alerts - mfd.ru
Published on: 2026-02-11 00:02:19 - baoquankhu1.vn
Alaunos Therapeutics Pivots to Obesity Drug Development in Race Against Time - AD HOC NEWS
Buybacks Report: Is Alaunos Therapeutics Inc a turnaround storyWeekly Earnings Recap & High Win Rate Trade Tips - baoquankhu1.vn
S P Trends: Should value investors consider Alaunos Therapeutics Inc.2025 Key Lessons & Stepwise Trade Signal Guides - mfd.ru
Swing Trade: Is Alaunos Therapeutics Inc a turnaround story2025 Price Targets & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Can Alaunos Therapeutics Inc stock double in the next year - baoquankhu1.vn
Is Alaunos Therapeutics Inc a cyclical or defensive stockTrade Ideas & High Accuracy Swing Trade Signals - baoquankhu1.vn
Fundamentals Check: truyen hinh quan khu mot ky 1 thang 11 ngay 11112019 1087 1July 2025 Market Mood & Low Volatility Stock Suggestions - baoquankhu1.vn
Published on: 2026-01-22 06:26:50 - baoquankhu1.vn
Why Alaunos Therapeutics Inc. stock could see breakout soonJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - bollywoodhelpline.com
Volume Report: Is BioSig Technologies Inc a turnaround storyJuly 2025 Review & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Downgrade Watch: Will Alaunos Therapeutics Inc benefit from rate cutsQuarterly Portfolio Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Why Alaunos Therapeutics Inc. stock could rally in 2025Trade Analysis Report & AI Driven Price Predictions - ulpravda.ru
Market Wrap: Why Alaunos Therapeutics Inc stock is favored by pension fundsJuly 2025 Final Week & AI Optimized Trade Strategies - Bộ Nội Vụ
Published on: 2026-01-09 20:19:14 - Улправда
Alveus debuts in obesity arena with $160m Series A - Pharmaceutical Technology
Why Alaunos Therapeutics Inc. stock is seen as undervalued2025 Price Momentum & Verified High Yield Trade Plans - Улправда
Will Alaunos Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Gainers & Real-Time Buy Signal Notifications - Улправда
Why Alaunos Therapeutics Inc. stock remains on buy listsJuly 2025 Sentiment & Short-Term High Return Ideas - Улправда
Bull Bear: Why Alaunos Therapeutics Inc. stock is favored by pension funds2025 Trading Volume Trends & Weekly Watchlist of Top Performers - Улправда
Alaunos Therapeutics Inc Azioni (TCRT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):